Evidence map›Paper›PMID 42581195›Full record

ArticleNature nanotechnology2026

A programmable DNA origami nanosyringe for directed membrane translocation.

Longjiang Ding, Sisi Fan, Xiang Hao, Xinxin Jing, Jiahui Liu, Andreas Peil, Pengfei Zhan, Dechang Li, Stephan Nussberger, Na Liu

Abstract read
PubMed Publisher
In one paragraph

Article in Nature nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Longjiang Ding2nd Physics Institute, University of Stuttgart, Stuttgart, Germany.
Sisi Fan2nd Physics Institute, University of Stuttgart, Stuttgart, Germany.
Xiang HaoDepartment of Biophysics, Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, Stuttgart, Germany.
Xinxin Jing2nd Physics Institute, University of Stuttgart, Stuttgart, Germany.ORCID http://orcid.org/0000-0001-5335-0387
Jiahui LiuInstitute of Biomechanics and Applications, Department of Engineering Mechanics, Zhejiang University, Hangzhou, China.
Andreas Peil2nd Physics Institute, University of Stuttgart, Stuttgart, Germany.
Pengfei ZhanHangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, China.ORCID http://orcid.org/0000-0002-1929-4403
Dechang LiInstitute of Biomechanics and Applications, Department of Engineering Mechanics, Zhejiang University, Hangzhou, China.ORCID http://orcid.org/0000-0002-9528-6851
Stephan NussbergerDepartment of Biophysics, Institute of Biomaterials and Biomolecular Systems, University of Stuttgart, Stuttgart, Germany.ORCID http://orcid.org/0000-0003-3619-4452
Na Liu2nd Physics Institute, University of Stuttgart, Stuttgart, Germany. na.liu@pi2.uni-stuttgart.de.ORCID http://orcid.org/0000-0001-5831-3382

Funding

Baden-Württemberg Stiftung (Baden-Württemberg Foundation) BWST-ISF2020-19Max-Planck-Gesellschaft (Max Planck Society) Max Planck Fellow
6 · The paper itself

Abstract

Bacterial contractile injection systems provide a model for membrane penetration and targeted delivery of molecular cargo through mechanical actuation. Replicating these features in synthetic nanoscale systems remains challenging, particularly with respect to coupling structural organization with dynamic actuation, reversibility and spatiotemporal regulation. Here we report a DNA origami nanosyringe that integrates these capabilities to enable programmable membrane translocation. The DNA origami nanosyringe comprises two ~70-nm DNA origami bundles crosslinked by a ~10-nm gold nanoparticle. One bundle forms a cholesterol-functionalized membrane-anchoring base, whereas the other serves as a DNA fuel-driven sliding needle. After binding to supported lipid bilayers or vesicle membranes, DNA-fuel actuation drives the needle downwards in ~14-nm steps, thereby enabling membrane penetration, while reverse actuation retracts the needle and promotes membrane resealing. We show that this device provides controllable delivery of cargo tethered to the needle tip into lipid-bounded compartments and can regulate biochemical processes within cell-sized environments, including membrane-localized hybridization chain reactions, RNA transcription and catalytic RNA cleavage. These results demonstrate a strategy for constructing dynamic DNA devices that operate at membrane interfaces and coordinate mechanical actuation with biochemical function.

Identifiers

PMID42581195

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.